Karl Swartling

Karl Swartling

Inga fler pågående positioner
61 år
Finance
Health Technology
Health Services

Profil

Mr. Karl A. Swartling is a Chief Executive Officer at Stena Sessan AB. He is on the Board of Directors at Affibody AB. Mr. Swartling was previously employed as a Managing Director by Sjätte AP-fonden, a Managing Director by Sjätte AP-fonden (Private Equity), a Managing Director by Investor Growth Capital AB, a Deputy Director by Atlas Antibodies AB, a Non-Executive Director by GHP Specialty Care AB, and a Principal by Mckinsey & Co., Inc. (Munich).
He also served on the board at Aerocrine AB, Cambio Healthcare Systems AB, Cellectricon AB, Global Health Partner Ltd., KTH Holding AB, Mando AB, Newron Sweden AB, PocketMobile Communications AB, Sörman Intressenter AB and Tobii AB. He received his MBA from Stockholm School of Economics.

Aktiva positioner av Karl Swartling

FöretagPositionStart
Direktör/Styrelseledamot -

Tidigare kända positioner av Karl Swartling

FöretagPositionSlut
Verkställande Direktör 2019-03-01
Verkställande Direktör 2019-03-01
President 2012-01-21
AEROCRINE AB Direktör/Styrelseledamot 2011-11-16
Mckinsey & Co., Inc. (Munich)
Företagsledare/Principal -
Se detaljerna i Karl Swartlings erfarenhet

Karl Swartlings utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

74

Första gradens relationer

18

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag18

Electronic Technology

Commercial Services

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Services

Health Services

Electronic Technology

Health Technology

Technology Services

Finance

Health Services

Technology Services

Commercial Services

Finance

Mckinsey & Co., Inc. (Munich)

  1. Börsen
  2. Insiders
  3. Karl Swartling
-40% : Prolongation exceptionnelle ➤➤➤➤
d
:
:
TA DEL AV DET NU